IMPACT OF COVID-19 IN PREGNANCY AND TEROTOGENICITY
During the coronavirus disease 2019 (COVID-19) pandemic, there are many unknowns for pregnant women. Pregnant women are now regarded potentially sensitive to severe SARS-CoV-2 infection based on clinical experience with pregnancies complicated by infection by other coronaviruses, such as Severe Acute Respiratory Syndrome (SARS) and Middle Eastern Respiratory Syndrome. The immune system, respiratory system, cardiovascular function, and coagulation are all affected by physiological changes during pregnancy. These might have a good or negative impact on the course of COVID-19 illness. The consequences of SARS-CoV-2 on implantation, foetal growth and development, labour, and newborn health have yet to be identified, and a concentrated, worldwide effort is needed to find out. Asymptomatic infection adds to the difficulty of providing services, preventing infection, and managing it. Aside from the disease's direct effects, the pandemic has a number of indirect effects on maternal health, including decreased access to reproductive health care, greater mental health strain, and increased socioeconomic hardship. In this review, we look at what we know about COVID-19 during pregnancy and where further study is needed to reduce the risk to mothers and their children